05/15/2025
2:18 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/30/2025
3:17 PM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
4:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
7:27 AM | BlackRock, Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025
3:27 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:17 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:34 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:40 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:56 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
3:13 PM | Supernus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
7:16 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SUPN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Supernus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/24/2025
7:18 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:20 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:22 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:47 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:50 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:41 PM | Sensenig Bethany (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:43 PM | Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:45 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:48 PM | Sensenig Bethany (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:42 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:43 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:44 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:45 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:47 PM | Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:54 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:20 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:13 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
3:57 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:33 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4/A | |
02/05/2025
3:37 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:23 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
3:59 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:01 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:04 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:26 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
3:33 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:13 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:42 AM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:31 AM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
$19 for a FULL YEAR of stock picks?! (Ad) Invest in Musk's AI Play With Just $100
You don't need deep pockets to ride the next wave of AI wealth.
Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock. Watch the exclusive AI investor briefing >>> |
12/03/2024
3:31 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:19 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:11 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
3:59 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
3:42 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:19 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:35 PM | MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
10:55 AM | DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:48 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:03 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:30 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:19 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:41 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:48 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
3:24 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
3:28 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:14 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:18 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:53 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:15 PM | Supernus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Buy SUPN Stock Free SUPN Stock Alerts